SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-095862
Filing Date
2023-12-15
Accepted
2023-12-15 06:09:00
Documents
14
Period of Report
2023-12-14
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190129-8k_incannex.htm   iXBRL 8-K 31421
2 LETTER TO SECURITIES AND EXCHANGE COMMISSION FROM PKF BRISBANE AUDIT, DATED DECE ea190129ex16-1_incannex.htm EX-16.1 3449
3 GRAPHIC ex16-1_001.jpg GRAPHIC 1645
  Complete submission text file 0001213900-23-095862.txt   214630

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ihl-20231214.xsd EX-101.SCH 3021
5 XBRL LABEL FILE ihl-20231214_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ihl-20231214_pre.xml EX-101.PRE 22364
8 EXTRACTED XBRL INSTANCE DOCUMENT ea190129-8k_incannex_htm.xml XML 3406
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 231488709
SIC: 2834 Pharmaceutical Preparations